Medisun PDT 1200

Medisun PDT 1200 ger smärtfri och kontrollerad exponering av aktinisk keratos. Den nya Medisun PDT 1200 representerar den logiska vidareutvecklingen av utomhusdagsljuset PDT och ”Redlight PDT”. Medisun PDT 1200 använder programmerbar flerfärgad högeffekts-LED. Med den nyutvecklade Medisun PDT 1200 får patienten en smärtfri exponering med ett optimerat dagsljusspektrum. Endast en timmes exponeringstid och är lika effektivt som det konventionella ”Redlight PDT”.

Med Medisun PDT 1200, kan du nu utföra daylight PDT när som helst på din klinik eller behandla med bara en timmes exponeringstid. Patienterna känner ingen smärta under exponeringen, till skillnad från många konventionella PDT enheter. Med Medisun PDT 1200 kan du också exponera mindre delar (ca 25x25cm) av huvudet eller andra delar på kroppen med aktiniska keratoser smärtfritt i en session. En joultimer tillåter en doseringsingång i J / cm och garanterar en exakt dos. Exponeringstiden beräknas automatiskt i minuter och sekunder. Vid slutet av exponeringen stängs LED-lampan av automatiskt.

Se ”mer info” och ”broschyr” nedan för mer information om produkten.

pdt1200

medisun daylight 1200

Fakta

Exponeringen med Medisun PDT 1200 är smärtfri. Under exponeringen kan patienten lyssna på musik, läsa, prata, eller bara koppla av.
Kräver endast en timmes exponeringstid.
Sparar tid för både patienten och personalen.
Medisun PDT 9000 kan användas året runt och när som helst på dygnet.
Terapin är planerbar och kan alltid styras med en reproducerbar dos.
Medisun PDT 1200 kräver lite utrymme och kan lätt installeras i alla rum.
Det behövs bara en normal 230 V strömförsörjning.
Inga strukturella förändringar är nödvändiga (såsom takmontage, ventilation, luftkonditionering, tre-fas anslutning, etc.).
Låga driftskostnader tack vare state-of-the-art Högeffekts-LED. Inget lampbyte krävs och mycket lite ström förbrukas.

(Snart kommer även PDT 1200 med tillbehöret PC-skärm)

medisun PDT 1200 is an innovative light treatment system for the painless exposure of photodynamic therapy (PDT) with polychromatic spectra from a high power LED light source. Thus, the medisun PDT 1200 is the ideal addition to the medisun PDT 9000.

The main indications are actinic keratoses, which are reported for a steady increase worldwide. Actinic keratoses are a preliminary stage to skin cancer, usually associated with excessive exposure to the sun during life, e.g. in outdoor occupations.

Therefore, the workmen`s compensation boards in Germany have recognized actinic keratosis as an occupational disease for many professions. Patients in these cases have a lifelong right to get paid the treatment costs.

Conventional red light PDT has been established for many years as it has proven to be very effective. However, the therapy protocols used are usually associated with great pain for the patients.

With the outdoor daylight PDT with natural sunlight, an alternative therapy protocol has been developed that contains all wavelengths of light and is less painful. However, the actual irradiance and the spectral composition of the light will depend on some uncontrollable factors such as the season, time of day, temperature, elevation above sea level, geographical location and weather conditions.

In certain weather conditions, e.g. below + 10 ° C, the outdoor daylight PDT can not be performed at all or the effect can not be calculated and is not reproducible. In addition, sunscreen must also be applied. However, the outdoor daylight PDT is considered to be less painful than the conventional red light PDT.

The new medisun PDT 1200 represents the logical further development of the outdoor daylight PDT and the red light PDT.

medisun PDT 1200 uses programmable multicolor high power LEDs. These can produce many monochromatic and polychromatic light mixtures.

With the newly developed medisun PDT therapy protocol, a painless exposure with an optimized daylight spectrum with only one hour of exposure time is possible, which is just as effective as the conventional red light PDT.

This has now been confirmed by a published clinical study by Prof. Dr. Thomas Dirschka and Prof. Dr. Rolf-Markus Szeimies.

The efficacy and freedom from pain during the exposure was also confirmed by a clinical study by Prof. Dr. med. Hans Michael Ockenfels (Hanau).

By using medisun PDT 1200 it is now possible to perform the painless PDT exposure planned in your practice throughout the year.

medisun PDT 1200 is equipped with a 3-axis adjustable lamp module. Single or multiple lesions (field cancerization) up to the entire head can be treated individually and homogeneously. Excellent tolerability and consistently excellent therapy results are achieved.

Thanks to the programmable controller, medisun PDT 1200 remains future-proof, regardless of which light spectrum will be of importance in the future.

All medisun products are developed and produced in Brühl near Cologne.

The medisun systems are certified as medical devices according to directive 93/42/EEC by TÜV-Rheinland LGA Products GmbH.

We rely on tested quality – Made in Germany.

Medisun PDT systems are already used in many university hospitals and dermatological practices.

We are happy to inform you competently and without obligation.